+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Immunodeficiency Diseases), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030- Product Image
Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Immunodeficiency Diseases), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Immunodeficiency Diseases), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 153 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5830909
Description Jump to:
The global intravenous immunoglobulin market size is estimated to reach USD 21.05 billion by 2030, expanding at a CAGR of 7.2% from 2025 to 2030. The increasing prevalence of immunodeficiency diseases, coupled with the adoption of intravenous immunoglobulin (IVIG) therapies, is expected to fuel market growth over the forecast period. In addition, increasing off-label use of immunoglobulin and investments in the healthcare sector are factors propelling the market growth. Moreover, increasing incidences of bleeding disorders and the growing geriatric population are the factors contributing to the industry growth.

The rising incorporation of subcutaneous immunoglobulin in the treatment of primary immunodeficiency diseases as well as in replacement therapy is anticipated to provide a growth platform to the market in the next seven years. Moreover, the key market players are focusing on breakthrough product introductions to expand their global distribution network. For instance, Octapharma U.S. got FDA clearance in July 2021 for Octagam 10%, its first intravenous immunoglobulin recommended for the treatment of the immune-mediated inflammatory illness known as dermatomyositis in adults.

The COVID-19 pandemic, which is currently in its last stages, is expected to boost the worldwide market for intravenous immunoglobulin. In India, for instance, Bharat Biotech is conducting a study to create monoclonal antibodies as a potential COVID-19 treatment. The Council of Scientific and Industrial Research (CSIR) has approved the project as part of its New Millennium Indian Technology Leadership strategy. Moreover, COVID-19 has caused substantial issues for patients with mental and neurological disorders due to their increased susceptibility to infection. For instance, in April 2021, Grifols, a key provider of plasma-derived medicines, contributed to a research study in collaboration with both the NIH and NIAID, to analyze an intravenous anti-SARS-CoV-2 hyperimmune globulin among outpatients. This is expected to provide a boost to the market growth in the forecast period.

Key players are adopting strategic alliances to sustain the competition. These initiatives include mergers & acquisitions, collaborations, and new product developments. For instance, in March 2022, Grifols' XEMBIFY has been approved in Europe, increasing access to novel medicines. Grifols' clearance in Europe allows it to extend its breakthrough European IG product range and offer patients and healthcare professionals another crucial therapy solution for primary and secondary immunodeficiencies. In February 2021, Pfizer gained US FDA clearance for the supplemental Biologics License Application (sBLA) with PANZYGA, an intravenous immunoglobulin to cure adult patients with severe inflammatory demyelinating polyneuropathy (CIDP).

Intravenous Immunoglobulin Market Report Highlights

  • The hypogammaglobulinemia application segment held the third-largest revenue share in 2024. This can be attributed to the increasing demand for immunoglobulin replacement therapies to treat hypogammaglobulinemia diseases, which is driven by rising awareness levels amongst patients and increasing incidences of the disease
  • Specialty pharmacy is expected to grow considerably over the forecast period. They offer the convenience of at-home treatment, making them an attractive option for many patients owing to the large network of hospitals and the convenient range of products that are easily accessible through hospital pharmacies. Furthermore, hospitals offer fast reimbursement, treatment, and proper care to a large number of patients, enabling a surge in the prevalence of patients selecting hospital pharmacie
  • The specialty pharmacy distribution channel segment is anticipated to expand at a lucrative CAGR during the forecast period as specialty pharmacies enable easy treatment at home
  • North America held the largest share of 46.11% in terms of revenue in 2024 due to the presence of a well-regulated healthcare system, the larger pool of target population, and high patient awareness pertinent to the plasma protein products
  • The IVIG market in Asia Pacific is expanding rapidly, driven by a significant increase in the incidence of immunodeficiency diseases, particularly in countries such as China, India, Japan, and Australia.
  • Countries such as India, China, and South Africa are expected to witness significant growth over the forecast period owing to improving healthcare facilities, rising healthcare expenditure, and growing public awareness regarding immune deficiency disorders
  • The Kawasaki disease segment is expected to exhibit the fastest growth in the market over the forecast period.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Intravenous Immunoglobulin (IVIG) Market Variables, Trends, & Scope
3.1. Parent Market Outlook
3.2. Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Rising prevalence of immunodeficiency diseases
3.3.1.2. Increasing adoption of immunoglobulin replacement therapy
3.3.1.3. Rising geriatric population
3.3.2. Market Restraints Analysis
3.3.2.1. Cost intensive nature of immunoglobulin replacement therapy
3.3.2.2. Stringent regulations pertaining to production and approvals
3.3.3. Market Challenge Analysis
3.3.3.1. Quality assurance and standardization-related challenges
3.3.3.2. Limited scope for multiple evaluations
3.4. Intravenous Immunoglobulin (IVIG) Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Intravenous Immunoglobulin (IVIG) Market: By Application Estimates & Trend Analysis
4.1. Intravenous Immunoglobulin (IVIG) Market: Application Segment Dashboard
4.2. Intravenous Immunoglobulin (IVIG) Market: By Application Movement Analysis, 2024 & 2030 (USD Million)
4.3. Immunodeficiency Diseases
4.3.1. Immunodeficiency Diseases Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.4. CIDP
4.4.1. CIDP Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Hypogammaglobulinemia
4.5.1. Hypogammaglobulinemia Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Congenital AIDS
4.6.1. Congenital AIDS Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Chronic Lymphocytic Leukemia
4.7.1. Chronic Lymphocytic Leukemia Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.8. Myasthenia Gravis
4.8.1. Myasthenia Gravis Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.9. Multifocal Motor Neuropathy
4.9.1. Multifocal Motor Neuropathy Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.10. ITP
4.10.1. ITP Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.11. Kawasaki Disease
4.11.1. Kawasaki Disease Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.12. Guillain-Barre Syndrome
4.12.1. Guillain-Barre Syndrome Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
4.13. Others
4.13.1. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Intravenous Immunoglobulin (IVIG) Market: Distribution Channel Estimates & Trend Analysis
5.1. Intravenous Immunoglobulin (IVIG) Market: Distribution Channel Segment Dashboard
5.2. Intravenous Immunoglobulin (IVIG) Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
5.3. Hospital Pharmacies
5.3.1. Hospital Pharmacies Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Specialty Pharmacies
5.4.1. Specialty Pharmacies Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Intravenous Immunoglobulin (IVIG) Market: Regional Estimates & Trend Analysis
6.1. Intravenous Immunoglobulin (IVIG) Market Share, By Region, 2024 & 2030, USD Million
6.2. North America
6.2.1. North America Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018- 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.8. Norway
6.3.8.1. Norway Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.3.9. Sweden
6.3.9.1. Sweden Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2017 - 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. UAE
6.6.3.1. UAE Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. Kuwait
6.6.4.1. Kuwait Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. South Africa
6.6.5.1. South Africa Intravenous Immunoglobulin (IVIG) Market Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis, 2024
7.4. Company Heat Map Analysis, 2024
7.5. Company Profiles
7.5.1. Biotest AG.
7.5.1.1. Participant’s Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Recent Developments/ Strategic Initiatives
7.5.2. Baxter.
7.5.2.1. Participant’s Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Recent Developments/ Strategic Initiatives
7.5.3. Octapharma AG
7.5.3.1. Participant’s Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Recent Developments/ Strategic Initiatives
7.5.4. LFB
7.5.4.1. Participant’s Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Recent Developments/ Strategic Initiatives
7.5.5. Grifols SA
7.5.5.1. Participant’s Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Recent Developments/ Strategic Initiatives
7.5.6. CSL.
7.5.6.1. Participant’s Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Recent Developments/ Strategic Initiatives
7.5.7. China Biologics Products Inc.
7.5.7.1. Participant’s Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Recent Developments/ Strategic Initiatives
7.5.8. Kedrion.
7.5.8.1. Participant’s Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Recent Developments/ Strategic Initiatives
7.5.9. BDI Pharma Inc.
7.5.9.1. Participant’s Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 4 Global Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 5 North America Intravenous Immunoglobulin (IVIG) Market, by Country, 2018 - 2030 (USD Million)
Table 6 North America Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 7 North America Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 8 U.S. Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 9 U.S. Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 Canada Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 11 Canada Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 12 Mexico Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 13 Mexico Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 14 Europe Intravenous Immunoglobulin (IVIG) Market, by Country, 2018 - 2030 (USD Million)
Table 15 Europe Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 16 Europe Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Germany Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 18 Germany Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 19 U.K. Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 20 U.K. Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 21 France Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 22 France Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Italy Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 24 Italy Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 25 Spain Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 26 Spain Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Denmark Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 28 Denmark Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Sweden Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 30 Sweden Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 31 Norway Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 32 Norway Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Intravenous Immunoglobulin (IVIG) Market, by Country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 36 China Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 37 China Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Japan Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 39 Japan Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 40 India Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 41 India Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 42 South Korea Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 43 South Korea Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Australia Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 45 Australia Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Thailand Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 47 Thailand Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Latin America Intravenous Immunoglobulin (IVIG) Market, by Country, 2018 - 2030 (USD Million)
Table 49 Latin America Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 50 Latin America Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Brazil Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 52 Brazil Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 53 Argentina Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 54 Argentina Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa Intravenous Immunoglobulin (IVIG) Market, by Country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 58 South Africa Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 59 South Africa Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 62 UAE Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 63 UAE Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Kuwait Intravenous Immunoglobulin (IVIG) Market, by Application, 2018 - 2030 (USD Million)
Table 65 Kuwait Intravenous Immunoglobulin (IVIG) Market, by Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & forecasting
Fig. 6 Market formulation & Validation
Fig. 7 Intravenous Immunoglobulin, Market Segmentation
Fig. 8 Market Snapshot, 2024
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five forces Analysis
Fig. 15 Global Intravenous Immunoglobulin Market: By Application Movement Analysis
Fig. 16 Global Intravenous Immunoglobulin Market, for Immunodeficiency Diseases, 2018 - 2030 (USD Million)
Fig. 17 Global Intravenous Immunoglobulin Market, for CIDP, 2018 - 2030 (USD Million)
Fig. 18 Global Intravenous Immunoglobulin Market, for Hypogammaglobulinemia, 2018 - 2030 (USD Million)
Fig. 19 Global Intravenous Immunoglobulin Market, for Congenital AIDS, 2018 - 2030 (USD Million)
Fig. 20 Global Intravenous Immunoglobulin Market, for Chronic Lymphocytic Leukemia, 2018 - 2030 (USD Million)
Fig. 21 Global Intravenous Immunoglobulin Market, for Myasthenia Gravis, 2018 - 2030 (USD Million)
Fig. 22 Global Intravenous Immunoglobulin Market, for Multifocal Motor Neuropathy, 2018 - 2030 (USD Million)
Fig. 23 Global Intravenous Immunoglobulin Market, for ITP, 2018 - 2030 (USD Million)
Fig. 24 Global Intravenous Immunoglobulin Market, for Kawasaki Disease, 2018 - 2030 (USD Million)
Fig. 25 Global Intravenous Immunoglobulin Market, for Guillain-Barre Syndrome, 2018 - 2030 (USD Million)
Fig. 26 Global Intravenous Immunoglobulin Market, for Others, 2018 - 2030 (USD Million)
Fig. 27 Global Intravenous Immunoglobulin Market: Distribution Channel Movement Analysis
Fig. 28 Global Intravenous Immunoglobulin Market, for Hospital Pharmacy, 2018 - 2030 (USD Million)
Fig. 29 Global Intravenous Immunoglobulin Market, for Specialty Pharmacy, 2018 - 2030 (USD Million)
Fig. 30 Global Intravenous Immunoglobulin Market, for Others, 2018 - 2030 (USD Million)
Fig. 31 Regional Marketplace: Key Takeaways Intravenous Immunoglobulin Market, Region 2018 - 2030 (USD Million)
Fig. 32 Regional Outlook, 2022 & 2030 Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 33 Global Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 34 North America Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 35 US Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 36 Canada Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 37 Mexico Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 38 Europe Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 39 Germany Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 40 UK Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 41 France Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 42 Italy Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 43 Spain Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 44 Denmark Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 45 Sweden Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 46 Norway Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 48 Japan Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 49 China Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 50 India Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 51 Australia Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 52 South Korea Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 53 Thailand Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 54 Latin America Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 55 Brazil Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 56 Argentina Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 57 Middle East and Africa Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 58 South Africa Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 60 UAE Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 61 Kuwait Intravenous Immunoglobulin Market, 2018 - 2030 (USD Million)
Fig. 62 Company/Competition Categorization
Fig. 63 Company Market Share Analysis, 2024
Fig. 64 Company Market Position Analysis, 2024
Fig. 65 Strategy Mapping

Companies Mentioned

  • Biotest AG
  • Baxter
  • Octapharma AG
  • LFB
  • Grifols SA
  • CSL
  • China Biologics Products Inc.
  • Kedrion
  • BDI Pharma Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages153
PublishedJanuary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 13.85 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.05 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Intravenous Immunoglobulin Market by Indication, Form, End-User - Global Forecast 2025-2030 - Product Image

Intravenous Immunoglobulin Market by Indication, Form, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Intravenous Immunoglobulin - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Intravenous Immunoglobulin - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Intravenous Immunoglobulin Market Report 2025 - Product Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Intravenous Immunoglobulin Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Intravenous Immunoglobulin Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 139 Pages
  • Global
From
Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report - Product Image

Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.